Rare diseases
Investigational molecules
Locations
Back to Italy2 684 clinical trials in Novara, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyStudy on the Safety and Effectiveness of Zagociguat for Treating MELAS in Patients
ItalyStudy Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer
ItalyStudy of cannabidiol (CardiolRx) in patients with recurrent pericarditis after stopping IL-1 blocker treatment
ItalyStudy Comparing Oral Fluoroquinolones or Trimethoprim-Sulfamethoxazole to IV Therapy in Stable Patients with Gram-Negative Blood Infections
ItalyLong-term safety study of zagociguat tablets in patients with MELAS syndrome (Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) who completed previous trial
ItalyStudy on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis
ItalyStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Atopic Dermatitis
ItalyStudy for Adults with Chronic Myeloid Leukemia Using Asciminib Alone or with Nilotinib
ItalyStudy on the Safety and Effects of IPN01195 in Adults with Advanced Solid Tumors
ItalyStudy of pacritinib effectiveness and safety compared to placebo in patients with VEXAS syndrome
ItalyStudy of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on hematologic malignancies and solid tumors, investigating innovative treatments for various cancer types including leukemia, breast cancer, and lung cancer.
Studies evaluating combination therapies and targeted treatments to improve patient outcomes.
Research focusing on heart failure prevention and treatment strategies, particularly exploring new drug combinations and their impact on cardiovascular outcomes.
Innovative approaches combining multiple therapeutic agents to address cardiovascular risks.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome and rheumatoid arthritis, with emphasis on novel therapeutic approaches.
Focus on developing targeted therapies for better disease management and patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
